Karima Mokhtari

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.7K citations

5-Year Analysis, Neuro-oncology, Oncology +8

Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas

Marc Sanson, Yannick Marie, Sophie Paris et al. · Journal of Clinical Oncology · 2009 · 993 citations · Full text

Radiotherapy for Glioblastoma in the Elderly

Florence Keime-Guibert, Olivier Chinot, Luc Taillandier et al. · New England Journal of Medicine · 2007 · 774 citations

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche, Frédéric Charlotte, Laurent Arnaud et al. · Blood · 2012 · 682 citations

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 661 citations · Full text

Neuro-oncology, Medicine, Therapeutic Implications +5